Doris O'Brien is a retired college Speech teacher and banker. She has published two books of humor (Up or Down With Women's Liberation and Humor Me a Little) and for many years contributed light verse to the Pepper 'n Salt column of the Wall Street Journal. She is an avid writer of letters to the editors.
Doris celebrated her 50th wedding anniversary in the same year she welcomed her first grandchild. She now lives in Pasadena with a great view of the San Gabriel mountains — and the annual Tournament of Roses Parade.
She can be reached by e-mail: witsendob at (@) gmail.com
Prices are Spiking for Homes, Cars and Gas; Don’t Be Alarmed, Economists Say
Republican political leaders are blaming Democratic President Joe Biden for accelerating inflation. But Jerome Powell, chairman of the US Federal Reserve Board, was appointed by Republican President Donald Trump — and the Fed says inflation will not be a long-term problem. Those numbers suggest that inflationary pressures are modest. Other dynamics, however, are unprecedented, reflecting deeper changes in the economy that may have accelerated with the pandemic. But at UC Berkeley, high-level economists are offering some calming advice: A measure of inflation is inevitable as the US economy comes back online, but it will likely be modest. And it will almost certainly blow over as the economy stabilizes. more »
Kaiser Family Foundation: FDA’s Approval of Biogen’s New Alzheimer’s Drug Has Huge Cost Implications for Medicare and Beneficiaries
"The question of what would happen when a new, expensive prescription drug comes to market for a disease like Alzheimer’s that afflicts millions of people has loomed large in discussions over drug prices in the U.S.— and now we’re about to find out. After a nearly 20-year dry spell in new treatments for Alzheimer’s disease, the Food and Drug Administration (FDA) just approved a new Alzheimer’s medication, Aduhelm (aducanumab), developed by Biogen, with an expected annual price tag of $56,000. While the scientific community debates the evidence of the effectiveness of this new drug, the FDA’s decision raises hope for Alzheimer’s patients and their families, along with serious cost concerns for patients and payers, particularly Medicare." more »
Security, Planning, and Response Failures: Senators Peters, Portman, Klobuchar, Blunt Release Bipartisan Report Investigating January 6th Capitol Attack
U.S. Senators Gary Peters (D-MI) and Rob Portman (R-OH), Chairman and Ranking Member of the Homeland Security and Governmental Affairs Committee, and Amy Klobuchar (D-MN) and Roy Blunt (R-MO), Chairwoman and Ranking Member of the Committee on Rules and Administration, released a bipartisan report on the security, planning, and response failures related to the violent and unprecedented attack on January 6th. The report also includes a series of recommendations for the Capitol Police Board, United States Capitol Police (USCP), federal intelligence agencies, the Department of Defense (DOD), and other Capital region law enforcement agencies. more »
U.S. Government Accountability Office: Science & Tech Spotlight: Renewable Ocean Energy
A Century of Non-Partisan Fact-Based Work: What is it? Renewable ocean energy (or, simply, ocean energy), is energy derived from the ocean's movement, or from its physical and chemical state. In the United States, ocean energy can be generated from waves, tides, and currents, as well as ocean temperature differences. The National Renewable Energy Laboratory estimates that if fully utilized, ocean energy resources in the U.S. could provide the equivalent of over half of the electricity that the country generated in 2019. U.S. government and industry stakeholders predict that ocean energy will likely be first used to provide power for energy and water needs of island and coastal communities and offshore activities. more »
